Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

GODAVARI DRUGS LTD.

Healthcare › Pharmaceuticals & Biotechnology
₹132.75
at close · 9 Oct 2026
▲ 3.55 (+2.75%)

Latest filings

  1. Godavari Drugs 38th AGM: all 4 resolutions passed, plans entry into nutraceuticals · Board & Shareholder Meetings
  2. Godavari Drugs 38th AGM: DHDT trials done, nutraceuticals push approved · Board & Shareholder Meetings
  3. Trading window closure from October 1 for half-yearly results · Compliance
All filings ↓
Ask Nexa about GODAVARI DRUGS LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹106 Cr over the trailing twelve months.

Market Cap
₹131 Cr
P / E (TTM)
23.8×
EV / EBITDA
16.8×
Div Yield
—
Growth
-2.9%▼
Revenue 5y CAGR
PAT -0.2% · EBITDA +2.3%
Quality
18.6%▲
ROCE (5y median)
ROE 11.3% (5y median) · margin 10.8%
Leverage
1.01·
Debt / Equity · moderate
Net debt ₹62 Cr
Revenue FY21→FY26
0.9×▼
Margin +0.5 pts
₹123 Cr → ₹106 Cr
Cash conversion
2.38×▲
Operating cash ÷ profit · 5 yrs
₹55 Cr on ₹23 Cr
Moves on a normal day
1.87%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#56/158
P/B#44/163
ROCE#130/183
ROE#114/166
Debt / Equity#154/166
EBITDA margin#122/165
Revenue growth#47/161
Profit growth#70/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Returns on capital 18.6% (5-year median)
#130 of 183 in Pharmaceuticals on the latest reported figures · down from 22.2% in FY21
Over 5 years it reported ₹23 Cr of profit and ₹55 Cr of operating cash — 2.38×
Profit is converting into cash
Concerns
Revenue shrinking over 5 years (−3% a year)
Profit shrinking over 5 years (0% a year)
Erratic profits — up in only 2 of the last 5 years
Carries more debt than its peers — 1.01× equity
higher than 93% of its 166 Pharmaceuticals peers
Heavy working capital — 190 days of cash tied up

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from GODAVARI DRUGS LTD.'s filed financials and exchange disclosures

What does GODAVARI DRUGS LTD. do?

GODAVARI DRUGS LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.

Is GODAVARI DRUGS LTD. profitable?

Yes. Over the trailing twelve months GODAVARI DRUGS LTD. reported a net profit of ₹4.09 Cr on revenue of ₹106 Cr.

Does GODAVARI DRUGS LTD. pay a dividend?

Not in the latest reported year — GODAVARI DRUGS LTD.'s dividend payout for FY26 was nil.

Is GODAVARI DRUGS LTD. debt-free?

No. It reported borrowings of ₹76 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹62 Cr after cash. Debt stands at 1.01× equity. That is higher than 93% of its 166 Pharmaceuticals peers.

Is GODAVARI DRUGS LTD. expensive compared with its peers?

On trailing P/E, GODAVARI DRUGS LTD. ranks 56 of 158 in Pharmaceuticals — cheaper than 65% of them, against an industry median of 31.2×. This is a position, not a valuation judgement.

How much does the GODAVARI DRUGS LTD. share price move in a day?

On a typical session GODAVARI DRUGS LTD. moves 1.87% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track GODAVARI DRUGS LTD.'s announcements?

Every NSE and BSE filing by GODAVARI DRUGS LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.